Anxiety, Affective Disorders and Schizophrenia

<

Neurosciences Programme

Research group

Group Leader

Antonio Bulbena Vilarrasa

The group is made up of different researchers involved in clinical work either in hospital or primary care. Although the backbone of the group is the original description (and derivative) of the association between anxiety and Joint Hypermobility Syndrome (JHS), current lines of research include bipolar illness, schizophrenia, first-episode psychosis, cognitive psychotherapy for anxiety, obsessive compulsive disorder, psychiatric emergency services, Hikikomori syndrome and also the expert patient. A very active group in ethological research also joined the group and has done pioneering research on the Noah Syndrome (animal hoarding), but is also remaining active on areas such as pet grief, human-animal interaction, etc.

The research group was recognized by AGAUR (Agència de Gestió d’Ajuts Universitaris i de Recerca, Generalitat de Catalunya) as a consolidated research group 2017-2020 (SGR 52; Principal investigator: Antonio Bulbena Vilarrasa).

Members

Anna Mané Santacana (Researcher)

Luis Miguel Martín López (Researcher)

Guillem Pailhez Vidual (Researcher)

Purificación Salgado Serrano (Researcher)

María José Tribó Boixareu (Researcher)

Esperanza González Fernández (Research Assistant)

Main PublicationsOngoing Research ProjectsClinical Trials Signed in 2019

Main Publications

• Ahmed AO, Kirkpatrick B, Galderisi S, Mucci A, Rossi A, Bertolino A, Rocca P, Maj M, Kaiser S, Bischof M, Hartmann-Riemer MN, Kirschner M, Schneider K, García-Portilla MP, Mané A, Bernardo M, Fernández-Egea E, Jiefeng C, Jing Y, Shuping T, Gold JM, Allen DN, Strauss GP. Cross-cultural Validation of the 5-Factor Structure of Negative Symptoms in Schizophrenia. Schizophrenia Bull 2019; 45(2): 305-314. IF 7.289. Q1.

• Bowen J, Fatjó J, Serpell JA, Bulbena-Cabré A, Leighton E, Bulbena A. First evidence for an association between joint hypermobility and excitability in a non-human species, the domestic dog. Sci Rep 2019; 9(1): 8629. IF. 4.011 Q1.

• Tribó MJ, Turroja M, Castaño-Vinyals G, Bulbena A, Ros E, García-Martínez P, Tausk F, Sagristà M, Pujol RM, Ferran M, Gallardo F. Patients with Moderate to Severe Psoriasis Associate with Higher Risk of Depression and Anxiety Symptoms: Results of a Multivariate Study of 300 Spanish Individuals with Psoriasis. Acta Derm-Venereol 2019; 99(4): 417-422. IF 3.531. Q1.

• Alba L, León-Caballero J, Córcoles D, González-Fresnedo AM, Bellsolà M, Martín LM, Pérez V. Unidad de Hospitalización Domiciliaria del Hospital del Mar. Equipo de atención psiquiátrica domiciliaria en el área de Barcelona. Rev Psiquiatr Salud Ment 2019; 12(4): 207-212. IF 2.927. Q3.

• Bulbena-Cabré A, Duñó L, Almeda S, Batlle-Vila S, Camprodon-Rosanas E, Martín LM, Bulbena A. La hiperlaxitud articular como marcador de ansiedad en niños. Rev Psiquiatr Salud Ment 2019; 12(2): 68-76. IF 2.927. Q3.

See all Publications

Ongoing Research Projects

• Rehabilitación cognitiva combinada con ejercicio físico en el tratamiento de la esquizofrenia: estudio controlado aleatorizado.

- Financing institution: Instituto de Salud Carlos III (PI15/00453)

- Period: from 2015 to 2020

- Principal investigator: Mané Santacana, Anna

See all Projects

Clinical Trials Signed in 2019

• Phenomics and Genomics of Clozapine Pharmacotherapy

- Sponsor: UMC Utrecht

- Protocol: ABR 52728.041.15

- Budget: No economic compensation